It’s important that health officials give close scrutiny to the conditions of major drug manufacturing and compounding pharmacies to ensure that medical products are being produced in a sterile environment.
Chicago, IL (PRWEB) November 02, 2012
Reacting to news that a voluntary recall had been issued by a company linked to the pharmacy at the center of a national outbreak of fungal meningitis and joint infection cases, Chicago drug injury lawyer Patrick A. Salvi said that pharmacy conditions are getting deserved scrutiny.
The U.S. Food and Drug Administration (FDA) announced October 31 that Massachusetts-based Ameridose, LLC, was voluntarily recalling all of its unexpired products in circulation.
According to Reuters, the company is owned by the same people who own the New England Compounding Center (NECC), the Massachusetts pharmacy linked to an outbreak of illnesses across the country due to contaminated steroid injections from its facility. The NECC recalled all of its products earlier this month.
The FDA said that preliminary findings in an inspection of Ameridose’s facility “have raised concerns about a lack of sterility assurance for products produced at and distributed by this facility.”
The recall was not based on any reports of patient infections associated with Ameridose products, the FDA added, but it had been recommended “out of an abundance of caution.”
“This voluntary recall is appropriate amid growing concerns about pharmacy conditions,” said Salvi, managing equity partner of the Chicago personal injury firm of Salvi, Schostok & Pritchard P.C. “It’s important that health officials give close scrutiny to the conditions of major drug manufacturing and compounding pharmacies to ensure that medical products are being produced in a sterile environment.
“If these drugs are produced in contaminated conditions, it puts patients at serious risk, especially when these are injectable drugs.”
Salvi’s firm is investigating reports of illnesses in Illinois and across the country that are potentially associated with the outbreak, which has shown no signs of slowing down.
On November 1, the U.S. Centers for Disease Control and Prevention (CDC) announced that 386 cases of fungal meningitis, stroke due to presumed fungal meningitis, peripheral joint infections and other central nervous system-related infections had been reported in 19 states. A total of 28 people have died, the CDC says.
According to the CDC and U.S. Food and Drug Administration, a black mold fungus called Exserohilum rostratum was found in two of three suspected lots of the steroid methylprednisolone acetate that was shipped out by the NECC prior to the pharmacy’s recall of the product on September 26, 2012.
Even though no illnesses have been linked to other NECC products, the FDA has advised doctors to follow up with patients who were administered any NECC injectable product on or after May 21, 2012, including those used in eye and cardiac procedures.
“As production is stopped and products are recalled, there certainly will be a concern about drug shortages,” Salvi said. “However, public health and safety is vitally important. The cautious approach is the best approach.”
About Salvi, Schostok & Pritchard P.C.
Salvi, Schostok & Pritchard P.C. is a leading Chicago personal injury firm with offices in Chicago (22 West Washington Street, Suite 1600, Chicago IL 60602) and Waukegan (218 North Martin Luther King Jr. Avenue, Waukegan, IL 60085). The firm represents clients in matters involving medication errors, emergency room errors, failure to diagnose, hospital negligence, physician error, birth injuries, surgical malpractice, anesthesia errors, organ puncture/perforation, post-operative and pre-operation malpractice and surgical complications. The firm’s success in medical negligence, personal injury and wrongful death cases features recoveries of more than $630 million on behalf of its clients, including more than 180 multi-million dollar verdicts or settlements. To learn more about Salvi, Schostok & Pritchard P.C., call (312) 372-1227 or use the firm’s online form.